These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome? Turhan H, Yetkin E. Int J Cardiol; 2006 Jun 16; 110(2):276-7. PubMed ID: 16364471 [Abstract] [Full Text] [Related]
11. Is it time to stop treating dyslipidaemia with fibrates? Benatar JR, Stewart RA. N Z Med J; 2007 Sep 07; 120(1261):U2706. PubMed ID: 17853928 [Abstract] [Full Text] [Related]
17. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid. Cardiovasc J Afr; 2008 Sep 07; 19(3):171-2. PubMed ID: 18568186 [No Abstract] [Full Text] [Related]
19. Clinical inquiries. What are effective medication combinations for dyslipidemia? Saseen J, Tweed E, Crawford P. J Fam Pract; 2006 Jan 07; 55(1):70-2. PubMed ID: 16388773 [No Abstract] [Full Text] [Related]
20. The use of lipid-lowering drug therapy in children and adolescents. Avis HJ, Vissers MN, Wijburg FA, Kastelein JJ, Hutten BA. Curr Opin Investig Drugs; 2009 Mar 07; 10(3):224-31. PubMed ID: 19333879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]